IL22 and psoriasis: STAT3 is an interesting target in the context of psoriasis as it is required for IL-6, IL-22, and IL-23 signaling and has been linked with the development of psoriasis in a transgenic mouse model (Sano et al., 2005; Figure 3 touches upon SOCS1-mediated TLR regulation briefly).